Arvinas (ARVN) Cash & Current Investments (2017 - 2026)

Arvinas (ARVN) recorded quarterly Cash & Current Investments of $614.9 million in Q1 2026, down 10.29% quarter-over-quarter from $685.4 million in Q4 2025, and down 35.57% on a YoY basis from $954.3 million in Q1 2025.

Arvinas (ARVN) Cash & Current Investments (2017 - 2026) Analysis & Trends

Arvinas' Cash & Current Investments history runs 10 years deep, the most recent figure standing at $614.9 million for Q1 2026.

  • In Q1 2026, Cash & Current Investments fell 35.57% year-over-year to $614.9 million; the TTM figure through Mar 2026 stood at $614.9 million (down 35.57% YoY), while the FY2025 annual figure was $685.4 million, down 34.06% from the prior year.
  • Cash & Current Investments was $614.9 million for Q1 2026 at Arvinas, down from $685.4 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $1.3 billion in Q4 2023 to a low of $66.8 million in Q1 2022.
  • Historically, Cash & Current Investments has averaged $552.2 million across 5 years, with a median of $614.9 million in 2026.
  • The sharpest annual moves came in 2022 and 2023: Cash & Current Investments sank 89.74% in 2022, then surged 1352.76% in 2023.
  • A 5-year view of Cash & Current Investments shows it stood at $86.8 million in 2022, then soared by 1352.76% to $1.3 billion in 2023, then decreased by 17.57% to $1.0 billion in 2024, then plunged by 34.06% to $685.4 million in 2025, then retreated by 10.29% to $614.9 million in 2026.
  • The last three Cash & Current Investments figures came in at $614.9 million (Q1 2026), $685.4 million (Q4 2025), and $787.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 2.13 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.20 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 7.25 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Arvinas 492.16 Mn -122.74 Mn - 614.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 614.90 Mn
Dec 31, 2025 685.40 Mn
Sep 30, 2025 787.60 Mn
Jun 30, 2025 861.20 Mn
Mar 31, 2025 954.30 Mn
Dec 31, 2024 1.04 Bn
Sep 30, 2024 1.12 Bn
Jun 30, 2024 1.23 Bn
Mar 31, 2024 93.50 Mn
Dec 31, 2023 1.26 Bn
Sep 30, 2023 119.20 Mn
Jun 30, 2023 96.10 Mn
Mar 31, 2023 135.70 Mn
Dec 31, 2022 86.80 Mn
Sep 30, 2022 138.10 Mn
Jun 30, 2022 97.70 Mn
Mar 31, 2022 66.80 Mn
Dec 31, 2021 112.80 Mn
Sep 30, 2021 260.16 Mn
Jun 30, 2021 600.58 Mn